Literature DB >> 11897569

Significance of intracellular Abeta42 accumulation in Alzheimer's disease.

T Tabira1, D H Chui, S Kuroda.   

Abstract

Abeta plays a pivotal role in the pathogenesis of Alzheimer's disease (AD), but it is still obscure how it causes AD. We have established transgenic mice carrying wild-type or familial Alzheimer's disease (FAD) mutant-type presenilin 1 (PS1). In these mice, the number of cortical and hippocampal neurons decreased along with age in mutant mice. In addition, the old mutant mice showed a significant increase of dark neurons by silver staining and the number of neurons with intracellular Abeta42 by immunohistochemistry. Our extended study also showed a significant increase of intracellular Abeta42-positive neurons in isolated cases of AD as well as in PS1 mutant FAD cases. These neurons frequently showed apoptotic staining. However, coincidence of apoptotic markers and intraneuronal neurofibrillary tangles (NFT) was insignificant. Notably intraneuronal Abeta42-labeling was frequently seen in a case of AD showing cotton-wool type senile plaques with a few NFT positive neurons and dystrophic neurites. These results indicate that intraneuronal deposition of Abeta42 is important in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897569     DOI: 10.2741/tabira

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  18 in total

1.  FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis.

Authors:  Tomomichi Watanabe; Yukiko Hikichi; Antje Willuweit; Yasushi Shintani; Takashi Horiguchi
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

2.  Reactive oxidative species enhance amyloid toxicity in APP/PS1 mouse neurons.

Authors:  Bin Yang; Xiaqin Sun; Hilal Lashuel; Yan Zhang
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

Review 3.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 4.  Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission.

Authors:  Anand Kant Das; Rucha Pandit; Sudipta Maiti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

5.  Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.

Authors:  Matthew J Winton; Edward B Lee; Eveline Sun; Margaret M Wong; Susan Leight; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 6.  Role of Endoplasmic Reticulum Stress and Unfolded Protein Responses in Health and Diseases.

Authors:  Abbas Ali Mahdi; Syed Husain Mustafa Rizvi; Arshiya Parveen
Journal:  Indian J Clin Biochem       Date:  2015-06-16

Review 7.  Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.

Authors:  Gunnar K Gouras; Davide Tampellini; Reisuke H Takahashi; Estibaliz Capetillo-Zarate
Journal:  Acta Neuropathol       Date:  2010-03-31       Impact factor: 17.088

8.  PPARα activation attenuates amyloid-β-dependent neurodegeneration by modulating Endo G and AIF translocation.

Authors:  Ya-Hsin Cheng; Shih-Wei Lai; Pei-Yi Chen; Jia-Hao Chang; Nai Wen Chang
Journal:  Neurotox Res       Date:  2014-07-22       Impact factor: 3.911

9.  Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model.

Authors:  Wenjuan Zhao; Sonya B Dumanis; Irfan Y Tamboli; Gustavo A Rodriguez; Mary Jo Ladu; Charbel E H Moussa; G William Rebeck
Journal:  Hum Mol Genet       Date:  2013-10-23       Impact factor: 6.150

10.  Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.

Authors:  Li Ling Lee; HyungHo Ha; Young-Tae Chang; Matthew P DeLisa
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.